Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Projected CAGR for the Pharmaceuticals Native Starch Market Size from 2025 to 2034?

The size of the pharmaceuticals native starch market has seen significant growth recently. The market is projected to expand from $5.65 billion in 2024 to $6.11 billion in 2025, at a compound annual growth rate (CAGR) of 8.1%. This substantial growth during the historic period is driven by several factors, which includes a higher demand for natural excipients, increased levels of pharmaceutical production, a growing preference for biocompatible ingredients, an upsurge in generic drug manufacturing, and increased regulatory support for natural components.

In the upcoming years, the market size of native starch in the pharmaceutical industry is predicted to experience substantial growth. It is projected to escalate to $8.5 billion by 2029, with a compound annual growth rate (CAGR) of 8.6%. The prospering growth during the forecasted period is linked to several factors including the upsurge in pharmaceutical innovation investments, growing emphasis on sustainable sourcing, increasing applications of innovative drug formulations, a surge in the demand for clean-label pharmaceutical products, and elevated healthcare spending in developing markets. Key trends expected to dominate the forecast period involve advancements in technology for starch processing, innovative strides in drug delivery systems, progression in bio-based pharmaceutical elements, research, and innovation in plant-derived excipients, and ways to enhance solubility and stability.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of thePharmaceuticals Native Starch Market?

The surge in chronic disease occurrence is predicted to spur the expansion of the pharmaceuticals native starch market. Chronic diseases are enduring medical conditions that usually progress gradually and last for a year or more. The surge in chronic diseases is primarily linked to the increasing aging population, with older individuals more prone to enduring health conditions like diabetes, cardiovascular diseases, arthritis, and cancer, which tend to become more prevalent with age. Pharmaceuticals native starch aids in managing chronic diseases by promoting stability in drug formulations, enhancing bioavailability, facilitating controlled drug release, encouraging patient compliance, and ultimately boosting the efficacy and long-term management of chronic health conditions. For example, as per the data from the Australian Institute of Health and Welfare, an Australian government agency, in June 2024, the mortality rate due to chronic conditions observed an increase, soaring from 459 per 100,000 individuals in 2021 to 490 per 100,000 individuals in 2022. Therefore, the ascending prevalence of chronic diseases is propelling the growth of the pharmaceuticals native starch market.

Which Segments in the Pharmaceuticals Native Starch Offer the Most Growth?

The pharmaceuticals native starch market covered in this report is segmented –

1) By Type: Potato Starch, Corn Starch, Other Types

2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations

3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent

4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents

5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users

Subsegments:

1) By Potato Starch: Modified Potato Starch, Native Potato Starch

2) By Corn Starch: Modified Corn Starch, Native Corn Starch

3) By Other Types: Rice Starch, Wheat Starch, Tapioca Starch

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=24376&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of thePharmaceuticals Native Starch Market?# Market?

North America was the largest region in the pharmaceuticals native starch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Pharmaceuticals Native Starch Industry?

Leading pharmaceutical companies in the native starch market are working on creating innovative products such as plant-based textures, intended to elevate drug formulation and foster increased patient conformity. Plant-based textures, derived from the physical properties of plant components like thickness and gel strength, aid the utilization of native starch in pharmaceuticals by elevating the tablet binding, disintegration, and mouthfeel for better natural drug formulations. For example, the US-based food company Ingredion Incorporated introduced Novation Indulge 2940 starch in February 2024, an innovative pharmaceutical native starch that provides functional benefits like enhancing drug formulation efficiency, bioavailability, and controlled remission, alongside contributing to the creation of sustainable, clean-label products. The Novation Indulge 2940 starch is a multi-functional ingredient that enriches texture, stability, and consumer approval in both dairy and dairy-alternative products, through the use of natural, clean-label ingredients.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report

What Are the Key Elements That Define the Pharmaceuticals Native Starch Market?

Pharmaceutical native starch is unaltered starch derived from natural sources such as corn, potato, wheat, or tapioca and utilized as an excipient in pharmaceutical formulations. It functions as a binder, disintegrant, or filler in tablets and capsules, helping to control medication release, increase stability, and maintain appropriate tablet formation without requiring chemical or physical change.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24376

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model